173 related articles for article (PubMed ID: 25218594)
1. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
Saxena A; Shoeb M; Tammali R; Ramana KV; Srivastava SK
Cancer Lett; 2014 Dec; 355(1):141-7. PubMed ID: 25218594
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice.
Kubota M; Shimizu M; Sakai H; Yasuda Y; Terakura D; Baba A; Ohno T; Tsurumi H; Tanaka T; Moriwaki H
Nutr Cancer; 2012; 64(1):72-9. PubMed ID: 22172229
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice.
Kochi T; Shimizu M; Sumi T; Kubota M; Shirakami Y; Tanaka T; Moriwaki H
BMC Gastroenterol; 2014 Dec; 14():212. PubMed ID: 25515685
[TBL] [Abstract][Full Text] [Related]
4. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Yasuda Y; Shimizu M; Shirakami Y; Sakai H; Kubota M; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Sci; 2010 Jul; 101(7):1701-7. PubMed ID: 20398056
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Kubota M; Shimizu M; Sakai H; Yasuda Y; Ohno T; Kochi T; Tsurumi H; Tanaka T; Moriwaki H
Biochem Biophys Res Commun; 2011 Jun; 410(1):108-13. PubMed ID: 21640075
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Sakai H; Adachi S; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2008 Sep; 1(4):298-304. PubMed ID: 19138973
[TBL] [Abstract][Full Text] [Related]
7. Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice.
Fukuta K; Shirakami Y; Maruta A; Obara K; Iritani S; Nakamura N; Kochi T; Kubota M; Sakai H; Tanaka T; Shimizu M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212276
[TBL] [Abstract][Full Text] [Related]
8. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc
Saxena A; Tammali R; Ramana KV; Srivastava SK
Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349
[TBL] [Abstract][Full Text] [Related]
9. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
Shimizu M; Shirakami Y; Iwasa J; Shiraki M; Yasuda Y; Hata K; Hirose Y; Tsurumi H; Tanaka T; Moriwaki H
Clin Cancer Res; 2009 May; 15(9):3068-75. PubMed ID: 19366832
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice.
Kato J; Shirakami Y; Mizutani T; Kubota M; Sakai H; Ibuka T; Shimizu M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210144
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.
Shukla K; Sonowal H; Saxena A; Ramana KV; Srivastava SK
Cancer Lett; 2017 Dec; 411():57-63. PubMed ID: 28986187
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation.
Tammali R; Reddy AB; Ramana KV; Petrash JM; Srivastava SK
Carcinogenesis; 2009 May; 30(5):799-807. PubMed ID: 19028703
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
Hirose Y; Hata K; Kuno T; Yoshida K; Sakata K; Yamada Y; Tanaka T; Reddy BS; Mori H
Carcinogenesis; 2004 May; 25(5):821-5. PubMed ID: 14729596
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
Rao CV; Kawamori T; Hamid R; Reddy BS
Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
[TBL] [Abstract][Full Text] [Related]
17. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
Miyamoto S; Yasui Y; Ohigashi H; Tanaka T; Murakami A
Chem Biol Interact; 2010 Jan; 183(2):276-83. PubMed ID: 19914226
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase regulates doxorubicin-induced immune and inflammatory responses by activating mitochondrial biogenesis.
Sonowal H; Saxena A; Qiu S; Srivastava S; Ramana KV
Eur J Pharmacol; 2021 Mar; 895():173884. PubMed ID: 33482179
[TBL] [Abstract][Full Text] [Related]
19. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.
Saxena A; Shoeb M; Ramana KV; Srivastava SK
Eur J Cancer; 2013 Oct; 49(15):3311-9. PubMed ID: 23827854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
